Post #77 by BenSolar on the Falling Knives board

Investment Strategies / Falling Knives

Unthreaded | Threaded | Whole Thread (12)

Post New | Post Reply | Report Post | Recommend It!

No. of Recommendations: 4

Pfizer is the poster child for a company pursuing growth through expensive acquisitions.

One of the things I've liked about Moderna's approach to their Covid profit windfall is they've been very restrained about pursuing acquisitions and instead have invested in building out their own R&D, production and sales capacity.

Of course they don't have the numerous streams of income that Pfizer does, so they'll feel the decline in Covid revenue far more sharply, and it's speculative that they'll succeed in bringing other blockbusters to market, or that Covid vaccine sales would rebound in any significant way from the levels projected for this year.

Post New | Post Reply | Report Post | Recommend It!

Print the post

Unthreaded | Threaded | Whole Thread (12)

Prev | Next

Announcements

Falling Knives FAQ

Contact Shrewd'm
Contact the developer of these message boards.

A community forum supporting civilized, and highly helpful, self-educating investors that come together for shrewdness and merry spirits. These message boards closely follow the look and feel of the old message boards at boards.fool.com prior to the boards redirected to discussion.fool.com. Shrewd'm is not affiliated with the comprehensive and excellent investment website, The Motley Fool (TMF), in any way. The Shrewd commmunity here has owed, and continues to owe, gratitude to The Motley Fool for nurturing a culture of jovial irreverence towards Wall St, and that tradition will continue here.